Health care VC hits new Indiana low in 2011
Indiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to the state’s health care sector since BioEnterprises began tracking such deals in 2005.
Health Care & Insurance
Articles
Drugmakers singing same song: 2012 will be tough
For drugmakers, the golden era of the 1990s and early part of the last decade, when they seemed to effortlessly churn out new multibillion-dollar pills for the masses along with double-digit quarterly profit increases, is not even in the rearview mirror any more.
Baldwin & Lyons ends tough year with quarterly profit
Indianapolis-based Baldwin & Lyons Inc. turned a profit in the fourth quarter, but it wasn’t enough to erase a dismal 2011 plagued by catastrophic losses.
Dow Agro posts record fourth quarter profit
The Indianapolis-based unit of Dow Chemical Co. saw earnings grow to $142 million, a fourth-quarter record and double the $72 million reported for the 2010 period.
Lilly eying deal with Turkish drug company
Eli Lilly and Co. is among about a half-dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in a deal that may value the Turkish drugmaker at $1 billion, sources say.
Community agrees to absorb Howard Regional
Kokomo’s Howard Regional Health System has signed a letter of intent to join the Community Health Network less than four months after it broke off a merger deal with Indiana University Health.
Lilly’s quarterly profit tumbles, but tops Wall Street estimates
Patent expirations on Gemzar and Zyprexa contributed to the 27-percent earnings decline, but CEO John Lechleiter touted better-than-expected sales of other products.
Symmetry Ex-CEO Moore to return $450,000 in clawback suit
Symmetry Medical Inc.’s former CEO will return $450,000 in pay and stock proceeds to resolve U.S. Securities and Exchange Commission claims that he profited from accounting fraud by a United Kingdom unit.
Purdue hopes center simplifies commercialization
Purdue University’s new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help developing their research into products and for outside investors to find out what research is taking place there.
Gallagher sees more broker mergers coming
The Carmel office of Arthur J. Gallagher & Co. just made its sixth acquisition in five years, and it expects looming changes to tax and health laws to produce even more chances to snap up benefits brokers this year.
Lilly’s ex-partner wins FDA approval for diabetes drug
Amylin Pharmaceuticals Inc. and Alkermes Plc have gained U.S. clearance for Bydureon, a once-weekly diabetes shot. Eli Lilly and Co. co-developed the drug, but ended its partnership with Amylin last year.
Indiana House backs break for bars on smoking ban
The Indiana House has added an 18-month exemption for bars to a bill calling for a broad statewide smoking ban.
UPDATE: WellPoint to boost primary-care pay
Health insurer WellPoint Inc. plans to improve primary care reimbursement and start paying for care management it doesn’t currently cover, changes that could give patients more quality time with their doctors.
Indiana House backs broader ban on synthetic drugs
The Indiana House has approved a bill that would broaden the state's ban on synthetic drugs to include compounds nicknamed "bath salts" and others that mimic marijuana.
Indiana Senate panel backs limits on abortion pill
The Senate health committee voted 5-4 in support of the bill that requires that a doctor examine a woman in person before giving her RU-486, provide written information about the physical risks of abortion and to schedule a follow-up ultrasound.
WellPoint shares sink after disappointing earnings report
WellPoint Inc.'s stock price dropped almost 5 percent Wednesday after the insurer's fourth-quarter earnings failed to meet analyst expectations.
WellPoint earnings fall well short of analysts’ expectations
The Indianapolis-based health insurer reported earnings of $335.3 million, or 96 cents per share, down 39 percent from the same quarter a year ago.
Eli Lilly unit plans to buy feed-enzyme maker
Drugmaker Eli Lilly and Co.'s Elanco animal health division plans to buy a privately held maker of feed-enzyme products that improve poultry, egg and meat production.
Poll: Anthem so-so in customer satisfaction
Anthem Blue Cross and Blue Shield ranked No. 12 in a new national customer satisfaction survey, but the poor showing doesn’t appear to threaten the Indianapolis-based company’s business success.<
Walgreen marks retailers’ push into health care
Health care reform is projected to cover 30 million more people with health insurance—and overwhelm the nation’s doctors. That’s why retailers like Walgreen and Wal-Mart are moving into the space in a big way.